Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hims, Citigroup
Citigroup Downgrades Hims & Hers Health (HIMS)
Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral to Sell. Analyst Price Forecast Suggests 8.29% Upside As of December 23, 2024,
Hims & Hers downgraded to Sell from Neutral at Citi
Citi downgraded Hims & Hers to Sell from Neutral with a $25 price target Stay Ahead of the Market:Discover outperforming stocks and invest
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review
Citi downgraded telehealth company Hims & Hers Health (NYSE:HIMS) to Sell from Neutral and upgraded value-based care provider agilon health (NYSE:AGL) to Neutral from Sell on Friday as part of its 2025 outlook for the U.
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation
Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High Risk, citing overvaluation concerns tied to its GLP-1 revenue stream. The stock slid more than 3% in
Citi downgrades Hims & Hers to Sell on valuation concerns
Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the
1h
on MSN
Hims & Hers Stock Is Poised for a Major Surge in 2025
Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...
1d
What's Going On With Hims & Hers Health Stock?
Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...
1h
Teladoc: Minimal Growth Left As More Healthcare Players Leave/Diversify
Teladoc's growth and profitability challenges continue amid rising competition. Learn why TDOC stock remains under pressure with future uncertainties.
3d
Even Hims & Hers is giving Trump money
The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...
15h
Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...
1d
Don't Buy Hims & Hers Stock If You Want Better Than Mediocre Returns
What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...
9d
Is Hims & Hers Health a Millionaire Maker?
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.
2d
on MSN
Here’s Cedar Grove Capital Management’s Investment Thesis for Hims & Hers Health (HIMS)
Cedar Grove Capital Management, an investment management company, released its fourth quarter 2024 investor letter. A copy of ...
2d
6 Best Weight Loss Treatments: Ranking Top Weight Loss Solutions of 2025
Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...
3d
on MSN
Hims & Hers donates $1 million to Trump's inauguration fund
OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
Citigroup
New York Stock Exchange
Homs
Indian National Congress
Feedback